SkinLite Cream To Treat Melasma

What Is The Use Of SkinLite Cream?

SkinLite is a topical skin cream used to treat melasma, asymmetrical, blotchy, brownish facial pigmentation characterized by the chronic skin disorder. Melasma is caused by melanin being overproduced by melanocytes, the cells containing pigments in the skin. Melasma is believed to be genetically predisposed and can be caused by a number of factors including sun exposure, pregnancy, hormone therapy, certain toiletries, and hypothyroidism (low thyroid hormone). SkinLite is a combination treatment that illuminates the skin and decreases the risk of dermatitis, a skin irritation that can be related to the use of skin lighteners alone. It also helps to minimize and lighten pigmented liver spots or age spots, also known as senile lentiginous associated with aging and damaged skin from the sun. Get your SkinLite topical reserved at no other but Livayush: Your beauty partner.

How Does SkinLite Cream Function?

SkinLite topical cream 25 g includes a variety of drugs used to treat chronic melasma skin disease. Melanin production is controlled by the tyrosine enzyme which is found in melanocyte melanosomes. Hydroquinone in SkinLite is a tyrosinase inhibitor that acts by inhibiting tyrosinase action, and this prevents formation of melanin by melanocytes. Hydroquinone in SkinLite also increases the breakdown of melanosomes containing melanin. The darkened skin slowly lightens as the amount of melanin created decreases to match natural skin color. Tretinoin in SkinLite cream is an active metabolite of vitamin A and is a keratolytic drug that works by binding to specific receptors of retinoic acid in the nucleus of skin cells and affects the behavior of skin cells, regulating cell growth and differentiation; it also has anti-inflammatory properties. Tretinoin is thought to act by increasing the proliferation of skin epithelial cells and promoting the differentiation of the epithelia..

Mometasone In SKinLite Cream

It also blocks outer skin layer hardening processes (keratinization and cornification) and increases the shedding of old hardened skin cells while promoting the growth of new skin cells. The combined effect of these acts is to increase skin cell turnover which will lighten the skin. SkinLite often contains the synthetic corticosteroid mometasone, which is an anti-inflammatory medium potency that is mainly used for topical application as it concentrates on the skin but does not reach the circulation of the blood and thus has a limited systemic effect. Mometasone in SkinLite works by taming the production and secretion of inflammatory chemicals such as leukotrienes and prostaglandins; and also contricts and narrows dilated (widened) leaky blood vessels that allow other inflammatory cells in the skin to escalate the inflammatory response. Mometasone’s anti-inflammatory actions in SkinLite Topical reduce the risk of developing hydroquinone and tretinoin-caused contact dermatitis.